Raj Rajagovindan

Company: Vigil Neuroscience

Job title: VP Clinical Development

Seminars:

Application of Fluid & Imaging Biomarkers to Drug Development in Adult-Onset Leukoencephalopathy 1:30 pm

Demonstration of proof-of-target engagement and pharmacological activity in early clinical development  Identification and characterization of biomarkers of disease pathophysiology and/or progression Application of such biomarkers to proof-of-concept studies Read more

day: Conference Day Two

Panel Discussion: What Are the Requirements for Validating CNS Biomarkers for Use as Surrogate Endpoints? 8:15 am

Striving for consensus on what is considered a reliable and relevant biomarker of neurodegeneration or neuroinflammation Evaluating the ability of amyloid and NfL biomarkers to provide reliable measurements of therapeutic effects on disease neuropathology Defining fluid and imaging biomarker standards to be used in the clinicRead more

day: Conference Day One